Mechanistically, a compelling body of study has suggested that the acquired CFTR dysfunction induced by CS and its increased oxidative stress at least in part plays a pathogenic role in obstructive airway diseases other than the CF, such as COPD, nonatopic asthma, and non-CF bronchiectasis. This evidence concerns the gene CFTR and asthma.